Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Revenue Recognition (Details)

v3.24.1.u1
Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Significant Accounting Policies    
Revenue $ 388,488 $ 302,077
Capitated revenue    
Significant Accounting Policies    
Revenue $ 384,134 $ 298,704
Capitated revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 98.90% 98.90%
Total other patient service revenue    
Significant Accounting Policies    
Revenue $ 4,354 $ 3,373
Total other patient service revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 1.10% 1.10%
Clinical fees & insurance revenue    
Significant Accounting Policies    
Revenue $ 1,945 $ 1,480
Clinical fees & insurance revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.50% 0.50%
Care coordination / management fees    
Significant Accounting Policies    
Revenue $ 2,390 $ 1,850
Care coordination / management fees | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.60% 0.60%
Incentive fees    
Significant Accounting Policies    
Revenue $ 19 $ 43
Incentive fees | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.00% 0.00%